DeFlame
- Product NDC
- 78863-1270
- Requested package NDC
- 78863-1270-2
- 11-digit product format
- 788631270
- Labeler code
- 78863
- Product ID
- 78863-1270_48648cb8-a891-4c35-8c25-4458a8b73517
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ALLANTOIN
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Noon Aesthetics M.R. Ltd
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-01
- Substance
- ALLANTOIN
- Active strength
- 5 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DeFlame
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ALLANTOIN | 5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 344S277G0Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 241509 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2628bd73-0ca9-497b-bcd9-088444cd62be | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 78863-1270-2 | NOON Cartessa Accelerate Program | 15 mL in 1 BOTTLE | CREAM | 15 mL | 5 mg in 1mL | 3 |
| 78863-1270-2 | NOON Post Procedure Program | 15 mL in 1 BOTTLE | CREAM | 15 mL | 5 mg in 1mL | 3 |
| 78863-1270-1 | DeFlame | 50 mL in 1 TUBE | CREAM | 50 | 2 | |
| 78863-1270-1 | DeFlame | 1 in 1 CARTON | CREAM | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 78863-1270 | NOON CARTESSA ACCELERATE PROGRAM (ALLANTOIN, TITANIUM DIOXIDE, OCTOCRYLENE, AND AVOBENZONE) KIT [NOON AESTHETICS M.R. LTD] | 3 | Current NDC | 20250130_400ead81-ab07-400f-b261-db330e0fd004.zip |
| 78863-1270 | NOON POST PROCEDURE PROGRAM (ALLANTOIN, TITANIUM DIOXIDE, OCTOCRYLENE, AND AVOBENZONE) KIT [NOON AESTHETICS M.R. LTD] | 3 | Current NDC | 20250130_9d1d11b4-40ff-4ea8-a3af-655f457c05f1.zip |
| 78863-1270 | DEFLAME (ALLANTOIN) CREAM [NOON AESTHETICS M.R. LTD] | 2 | Current NDC, 2 package rows | 20250130_2628bd73-0ca9-497b-bcd9-088444cd62be.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Banana Boat | AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE OXYBENZONE | Edgewell Personal Care Brands, LLC | 39a5a3be-f9a7-4fa1-e054-00144ff88e88 | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | AVOBENZONE HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fda2f46-4322-1284-e054-00144ff8d46c | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | AVOBENZONE HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fd8448c-5b3a-1a76-e054-00144ff88e88 | 2026-10-27 | Warnings | M020 |
| BANANA BOAT | HOMOSALATE OCTOCRYLENE | Edgewell Personal Care Brands, LLC | 0fd69dcf-95e3-73bb-e054-00144ff8d46c | 2026-10-27 | Warnings | M020 |
| ANTI-AGING COMPLEX BROAD SPECTRUM SPF 30 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Merle Norman Cosmetics, Inc. | d10272ea-aedd-5759-e053-2a95a90a3ab3 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb338c7-e99c-887d-e063-6394a90a977c | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | M020 |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | M020 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 241509 | allantoin 0.5 % Topical Cream | PSN | 400ead81-ab07-400f-b261-db330e0fd004 | 3 |
| 241509 | allantoin 0.5 % Topical Cream | PSN | 9d1d11b4-40ff-4ea8-a3af-655f457c05f1 | 3 |
| 241509 | allantoin 5 MG/ML Topical Cream | SCD | 400ead81-ab07-400f-b261-db330e0fd004 | 3 |
| 241509 | allantoin 5 MG/ML Topical Cream | SCD | 9d1d11b4-40ff-4ea8-a3af-655f457c05f1 | 3 |
| 241509 | allantoin 0.5 % Topical Cream | SY | 400ead81-ab07-400f-b261-db330e0fd004 | 3 |
| 241509 | allantoin 0.5 % Topical Cream | SY | 9d1d11b4-40ff-4ea8-a3af-655f457c05f1 | 3 |
| 241509 | allantoin 0.5 % Topical Cream | PSN | 2628bd73-0ca9-497b-bcd9-088444cd62be | 2 |
| 241509 | allantoin 5 MG/ML Topical Cream | SCD | 2628bd73-0ca9-497b-bcd9-088444cd62be | 2 |
| 241509 | allantoin 0.5 % Topical Cream | SY | 2628bd73-0ca9-497b-bcd9-088444cd62be | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 78863-1270-2 | 78863127002 | 1 BOTTLE, PUMP in 1 CARTON (78863-1270-2) / 15 mL in 1 BOTTLE, PUMP | 2026-07-28 | No | No | Current |